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Abstract: Soybeans and soy-based products contain isoflavones which can be used for nutraceutical
and medical applications. In soybeans and in unfermented soy foods, isoflavones are normally
present as glycosides. Isoflavone glycosides can be enzymatically converted to isoflavone aglycones,
thus releasing the sugar molecule. The effective absorption of isoflavones in humans requires the
bioconversion of isoflavone glycosides to isoflavone aglycones through the activity of the enzyme β-
glucosidase. The objective was to assess the capacity of 42 bacterial strains (belonging to Lactobacillus,
Streptococcus and Enterococcus) to produce β-glucosidase activity. The strain that showed the highest
β-glucosidase activity (Lactobacillus plantarum 128/2) was then used for the optimization of the
bioconversion of genistin and daidzin present in commercial soymilk to their aglycone forms genistein
and daidzein. The contribution of process parameters (temperature, inoculum size, time) to the
efficiency of such bioactivation was tested. Lactobacillus plantarum 128/2 was able to completely
bioactivate soymilk isoflavones under the following conditions: 25 ◦C temperature, 2% inoculum size
and 48 h process time. These results confirm the suitability of lactic acid bacteria for the bioactivation
of isoflavones present in soymilk and provide an interesting candidate (L. plantarum 182/2) for food
industries to perform this transformation.
Keywords: β-glucosidase; isoflavone glycosides; isoflavone aglycones; nutraceuticals; phytoestrogens
1. Introduction
Isoflavones are a group of flavonoids similar in structure and biological activity to
endogenous 17β-estradiol [1]. Due to this structural similarity to the human female hor-
mone 17β-estradiol, isoflavones can bind to estrogen receptors and show estrogen-like
activities. Isoflavones are present in large quantities in legumes [2] and have attracted
considerable interest in the last decades and years due to their possible beneficial ef-
fects for a variety of human diseases and their potential for the development of func-
tional foods. In fact, the consumption of isoflavones has long been linked to a variety of
health benefits such as, for instance, lower risk of cardiovascular disease and breast and
prostate cancer, attenuated menopausal symptoms, prevention of bone loss, osteoporosis,
etc. [1,3–5]. Nonetheless, isoflavones have also been reported as potential endocrine dis-
ruptors and, hence, with the capacity to cause adverse effects on human health [5,6].
Actually, there are growing concerns about an excessive exposure of humans to isoflavones
owing to their estrogen-like properties [7,8]. At this time, there seems to be a consensus
regarding the need for more studies on this issue, in order to confirm, rule out or put into
context the potential health benefits (possibly, modest effects) linked to the consumption of
soy isoflavones [2,9].
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Soybeans (Glycine max L.) and soy-based foods are the major source of isoflavones in
the human diet. In Asia, soybeans are consumed without much processing, whereas in
western countries soy-based products are consumed in highly processed forms [5]. It has
been reported [5,10] that processed soy products may not have the same health benefits as
the unprocessed soy foods. In any case, in an attempt to benefit from the abovementioned
potential positive effects of isoflavones on human health, the consumption of soymilk (as
well as its by-products) and foodstuffs enriched with isoflavones is often encouraged.
In soybeans and in unfermented soy foods, isoflavones are usually present in a
conjugated form (linked to sugars) [3]. In fact, soy isoflavones can exist as glycosides
(conjugated to sugars) or as aglycones (hydrolysates of isoflavone glycosides). In the
human gut, isoflavone glycosides are hydrolyzed to their corresponding aglycone forms
(by bacteria that colonize the human intestine) which are then easily transported across
intestinal epithelial cells [11]. Unlike aglycones, glycosides cannot be absorbed owing to
their higher hydrophilicity and higher molecular mass and, therefore, they can be metab-
olized only when hydrolyzed [5,12]. The effective absorption of isoflavones requires the
bioconversion of glycosides to aglycones through the activity of the enzyme β-glucosidase
produced by gut bacteria [3]. Then, the absorption of isoflavones in humans can differ
among populations due to factors such as the composition of the intestinal microbiota,
dietary habits, ethnic background, etc. [13,14]. Bacterial species of Bacteroides, Bifidobacteria
and Lactobacilli have been reported to show the highest levels of β-glucosidase activity [15].
Interestingly, it has been observed [16] that the chronic ingestion of soy can lead to an
increase of intestinal β-glucosidase activity. However, the efficiency of the enzymatic
bioconversion of isoflavone glycosides to isoflavone aglycones depends on many factors,
such as the microbial species, inoculum size, process time, temperature, etc. For instance,
temperature is well-known to affect the growth of microorganisms and, hence, the activity
of the enzymes produced by them.
Genistin (4′,5,7-trihydroxyisoflavone), daidzin (4′,7-dihydroxyisoflavone) and glycitin
(7,4′-dihydroxy-6-methoxy-isoflavone) are the most relevant soy isoflavone glycosides [15].
Their corresponding isoflavone aglycones are termed genistein, daidzein and glycitein.
In the conjugated form, soy isoflavones can be present as glucosides, acetylglucosides
(6”-O-acetyldaidzin, 6”-Oacetylgenistin, 6”-O-acetylglycycitin) and malonylglucosides (6”-
O-malonyldaidzin, 6”-O-malonylgenistin, 6”-O-malonylglycitin) [17]. Thus, soybeans con-
tain three types of isoflavones in four chemical forms: glucosides (daidzin, genistin,
glycitin), acetylglucosides (acetyldaidzin, acetylgenistin, acetylglycitin), malonylgluco-
sides (malonyldaidzin, malonylgenistin, malonylglycitin) and aglycones (daidzein, genis-
tein and glycitein), resulting in a total of 12 different isoflavones [2]. The type and con-
tent of these isomers in foods varies, among other aspects, depending on the plant part
from which they are derived and the method by which they are processed [10,18,19].
Genistein, daidzein and glycitein comprise approximately 50, 40 and 10% of soy isoflavone
content, respectively [4,20].
Some relevant non-fermented soy-based food products are: soymilk, tofu, yuba,
soybean sprouts, okara, roasted soybeans, soy nuts, soy flour, etc. Similarly, important fer-
mented soy-based food products are soy paste, soy sauce, tempeh, natto, soy nuggets, sufu,
etc. [2]. Fermentation of soybeans is known to alter their content of isoflavones: for instance,
the content of genistein in fermented soybean products is higher than in unfermented
soybeans and soybean products such as soymilk and tofu [3]. Indeed, although the fermen-
tation of soy can significantly reduce the total content of isoflavonoids [11], their bioavail-
ability is normally higher in fermented products [3,11].
Some authors [8] have studied the content of isoflavones in soy agricultural waste.
Apart from the possibility of obtaining a high-added value product from such waste,
their management and processing could also help mitigate undesirable impacts to the
environment, since the soy waste left in the agricultural field might be leached by rain-
water causing environmental contamination with phytoestrogens [8]. This strategy is
in accordance with the circular bioeconomy paradigm (the term bioeconomy refers to
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the production of renewable biological resources and their transformation into nutrients,
bio-based products, and bioenergy). Actually, the production of pharmaceuticals and
nutraceuticals (such as those derived from soy isoflavones) is one of the main goals of
many bioeconomy and bio-based economy studies. Nowadays, the development and
implementation of circular bioeconomy and bio-based initiatives for creating value-added
products is highly encouraged.
The objectives of this study were: (i) to examine the capacity of 42 bacterial strains
(belonging to Lactobacillus, Streptococcus and Enterococcus) to produce β-glucosidase activity,
(ii) to assess the isoflavone content of different soy-based products, and (iii) to test the ca-
pacity of the strain that showed the highest β-glucosidase activity to drive the bioactivation
of genistin and daidzin present in commercial soymilk to their corresponding aglycone
forms genistein and daidzein. The contribution of some process parameters (temperature,
inoculum size, and time) to the efficiency of such bioactivation was tested.
2. Materials and Methods
2.1. Materials
Soybeans (Glycine max L.) and commercial soy-based products (three soymilks called
here, for confidentiality purposes, No. 1, No. 2, and No. 3, and two soy-based yoghurts
called here No. 4 and No. 5) were purchased from a local market. For comparison purposes,
a homemade soy milk was also prepared as follows: the soybeans were washed and soaked
overnight in distilled water (1: 6 w/v ratio of soybeans to water). The soaked soybeans
were then cooked at 90 ◦C for 20 min in a 2 L beaker. After decanting the liquid phase,
soybeans were crumbled in a blender (MX050 Dynamic, Mortagne-sur-Sèvre, France) and
the resultant slurry was filtered with double layers of cheesecloth to remove solid particles.
Afterwards, the liquid was transferred into glass bottles (Duran Group, Wertheim/Main,
Germany) and sterilized by autoclaving at 121 ◦C for 15 min. The resulting homemade
soymilk was cooled and, finally, stored at 4 ◦C until use.
Reagents for the preparation of bacterial culture media (Man Rogosa Sharpe-MRS
broth and Brain Heart Infusion-BHI broth) were obtained from Sigma-Aldrich (Stein-
heim, Germany). For the determination of β-glucosidase activity, p-nitrophenyl β-D-
glucopyranoside (pNPG) and p-nitrophenol were purchased from Sigma-Aldrich (Stein-
heim, Germany). Isoflavone glycosides (daidzin and genistin) and corresponding agly-
cones (daidzein and genistein) were purchased from Sigma-Aldrich (Steinheim, Germany).
Isoflavones were diluted to 1000 mg L−1 solutions using dimethyl sulfoxide (DMSO) (99.9%,
LabScan, Dublin, Ireland). Acetic acid (99.7%) and acetonitrile (99.9%) were obtained from
Panreac (Barcelona, Spain). Methanol (MeOH), ethyl acetate and n-hexane (HPLC quality)
were obtained from LabScan (Dublin, Ireland). Disodium hydrogen phosphate (100%)
(Panreac, Barcelona) and citric acid (99.5%) (Sigma-Aldrich, Steinheim) were used for the
preparation of the required buffer solution (5 mmol, pH 6.8).
Finally, all bacterial strains studied here were kindly provided by the Dairy Institute
of Asturias (CSIC, Villaviciosa, Spain).
2.2. Preparation of Bacterial Inocula
The first objective of this study was to assess the capacity of 42 bacterial strains (be-
longing to Lactobacillus, Streptococcus and Enterococcus) to produce β-glucosidase activity.
To this purpose, 27 Lactobacillus strains were maintained in MRS agar stabs at 4 ◦C (Table 1).
After two successive transfers in MRS broth at 37 ◦C for 12–15 h, Lactobacillus cells in expo-
nential phase were re-inoculated into MRS broth and grown at 37 ◦C for 16 h. These bacte-
rial cultures were used as inoculum for the below-mentioned tests on β-glucosidase activity.
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Table 1. Lactobacillus, Streptococcus and Enterococcus strains used in this study.
Strain Culture Medium
1 L. acidophillus MRS a
2 L. acidophillus 4353 MRS a
3 L. brevis 3810 MRS a
4 L. brevis 3811 MRS a
5 L. brevis 3824 MRS a
6 L. brevis 4121 MRS a
7 L. brevis 5354 MRS a
8 L. brevis C310 MRS a
9 L. casei MRS a
10 L. delbruecki 11842 MRS a
11 L. delbruecki 20074 MRS a
12 L. fermentum 4339 MRS a
13 L. fermentum PND4 MRS a
14 L. gasseri 98552 MRS a
15 L. gasseri H633 MRS a
16 L. leichmanii MRS a
17 L. paraplantarum CuB7 MRS a
18 L. plantarum 128/2 MRS a
19 L. plantarum MCMB 8826 MRS a
20 L. plantarum LC441 MRS a
21 L. plantarum LPC 01 nic 100 MRS a
22 L. rhamnosus CR1 MRS a
23 L. reuteri 213 MRS a
24 L. reuteri PND1 MRS a
25 L. reuteri PND3 MRS a
26 L. reuteri PND7 MRS a
27 L. helveticus MRS a
28 S. thermophillus CN RZ 1066 BHI b
29 S. thermophillus CN RZ 1205 BHI b
30 S. thermophillus CMD9 BHI b
31 S. thermophillus 5 BHI b
32 S. thermophillus 6.10.2 BHI b
33 S. thermophillus 6.6.1 BHI b
34 S. thermophillus 3.2.4 BHI b
35 S. thermophillus 111.2 BHI b
36 E. faecium CM17 HFS14 BHI b
37 E. faecium CM17 HFS7 BHI b
38 E. duraus C6 BHI b
39 E. faecalis BHI b
40 E. faecium CM17 C39 BHI b
41 E. faecium CM17 HFS11 BHI b
42 E. duraus CELT 441 BHI b
a MRS: Man Rogosa Sharpe, b BHI: Brain Heart Infusion.
Moreover, eight strains of Streptococcus thermophillus and seven strains of Enterococcus
were maintained in BHI agar stabs at 4 ◦C (Table 1). After two successive transfers in BHI
broth at 37 ◦C for 24 h, bacterial cells in exponential phase were re-inoculated into BHI
broth and grown at 37 ◦C for 24 h. Similarly, these bacterial cultures were used as inoculum
for the below-mentioned tests on β-glucosidase activity.
2.3. β-Glucosidase Activity
The β-glucosidase activity of all the bacterial strains was quantified as described
in Di Cagno et al. [21]. Briefly, the reaction mixture contained 500 µL of 0.5 mM pNPG
in 5 mM phosphate/citrate buffer (pH 6.8), and 500 µL of the corresponding bacterial
cell suspension at an optical density (OD600) of 1.0. The mixture was incubated at 40 ◦C
for 30 min. Then, the reaction was stopped by the addition of 500 µL of an ice-cold
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2 M sodium carbonate solution. The mixture was then centrifuged (14,000 rpm, 5 min)
(Beckman Coulter Avanti J-26 XP, Fullerton, California, USA) and the amount of released p-
nitrophenol was spectrophotometrically (Shimadzu UV-2401PC, Tokyo, Japan) determined
at 400 nm. One unit (U) of enzyme activity was defined as the amount of β-glucosidase that
releases 1 µmol of p-nitrophenol per milliliter and per min, under the assayed conditions.
2.4. Quantification of Isoflavones
Once the 42 bacterial strains had been tested for their capacity to produce β-glucosidase
activity, isoflavone content was determined in the five abovementioned commercial soy-
based products (three milks, two yoghurts), as well as in the homemade soymilk. The extrac-
tion of isoflavones from these food products was carried out as described by Otieno et al. [22]
and Otieno and Shah [23]. Briefly, soy-based products were diluted fifteen times with
MeOH. Then, 1 mL of this solution was heated in an oven at 65 ◦C for 30 min. The insoluble
residue was separated by centrifugation (3700 rpm, 5 min, 4 ◦C), while the supernatant
was evaporated to dryness under a gentle stream of nitrogen in a Turbovap LV Evaporator
(Zymark, Hopkiton, MA, USA). The concentrated extract was re-dissolved in 1 mL of the
mobile phase: 1% (v/v) acetic acid in water and 1% (v/v) acetic acid in MeOH at a ratio
of 85:15 (v/v). Finally, the extract was filtered with a 0.45 µm syringe filter (Millipore®,
Bedford, MA, USA) and introduced into a HPLC vial.
Isoflavone content was determined by HPLC (Agilent Technologies, Avondale, PA, USA)
using an Agilent DAD detector and an Agilent autosampler. Two microliters of the above-
mentioned extract were injected in a ZorbaxEclipse XDB-C18 (150× 4.6 mm, 5 µm) column.
The samples were eluted at 1 mL min−1 with a linear gradient of 1% (v/v) acetic acid in
water (A) and 1% (v/v) acetic acid in MeOH (B). The elution gradient (a four-step linear
gradient) was started immediately after injection. The elution gradient was as follows:
15% B was maintained for 1 min, later increased to 40% B for 6 min, and then to 60% B
for 30 s, where it was held constant for 2.5 min. At the end of the run, the column was
re-equilibrated with 15% B for 2 min before the next run. The DAD was operated between
200 and 800 nm, and chromatograms for quantitative analysis were extracted at 254 nm.
Isoflavones were identified by their retention time. Multi-wavelength UV spectrums were
compared with those of standards. Calibration curves for genistin, daizin, genistein and
daizein were obtained using concentrations in the range of 0.02–20.00 µg mL−1.
2.5. Bioactivation of Isoflavones in Soymilk
After testing the 42 bacterial strains, it was observed that Lactobacillus plantarum 128/2
showed the highest β-glucosidase activity and, in consequence, it was selected for the study
of the optimization of the bioactivation of genistin and daidzin present in soymilk to their
corresponding aglycone forms (genistein and daizein). To this purpose, the commercial
soymilk No. 1 was used, as it presented the highest isoflavone content (see below).
Initially, L. plantarum 128/2 cells were propagated twice in 10 mL of MSR broth at
37 ◦C for 12–15 h, to obtain an OD600 of 1.0. Then, the commercial soymilk No. 1 was
inoculated with this bacterial culture (2% v/v = inoculum size) and kept at 25 ◦C and 37 ◦C
for 24 h (to evaluate the effect of growth temperature on the abovementioned bioactiva-
tion). Subsequently, samples from the inoculated soymilk were aseptically withdrawn and
immediately cooled on ice to then measure isoflavone content.
Similarly, the effects of inoculum size (2% vs. 10%) and process time (24 h vs. 48 h)
were also tested, in order to optimize process conditions. All tests were run in triplicate.
2.6. Statistical Analysis
Results are presented as mean values ± standard deviations. One-way analysis of
variance (ANOVA) was used for comparisons among β-glucosidase activities. A p-value < 0.05
was considered as statistically significant.
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3. Results and Discussion
3.1. β-Glucosidase Activity
Nowadays, the consumption of soy-based food products is often being encouraged
in many western countries where, unlike in many Asian countries, soy has traditionally
not been an integral part of the regular diet. The consumption of these products has been
linked to a variety of potential positive health effects (e.g., reduction in incidence and
severity of cardiovascular diseases, breast and prostate cancer, menopausal symptoms,
etc.) [1,3–5], but some potential adverse health effects have also been reported [5,6,8,13].
In consequence, at the moment, a regular recommendation, for precautionary reasons, is to
consume moderate amounts of traditionally prepared, minimally processed soy foods [2],
in an attempt to benefit from the positive properties of soy isoflavones while minimizing
their potential adverse health effects [24], until more extensive rigorous studies on this
topic are performed.
One of the most common soy-based products consumed in western countries is
soymilk. As previously mentioned, soy isoflavone composition appears a key determinant
of isoflavone effects. In this respect, the absorption of soy isoflavone in humans highly
depends on the conversion of isoflavone glycosides to their corresponding aglycones
through the activity of the enzyme β-glucosidase produced by gut bacteria [3,15]. In ad-
dition, thanks to the activity of the gut microbiota, daidzein may later be metabolized to
form equol (7-hydroxy-3-(4′-hydroxyphenyl)-chroman) and O-desmethylangolensin [25].
The ability to produce equol (not all soy consumers produced it efficiently) [12] appears
determinant for the claimed beneficial effects of isoflavones [26,27]. Finally, in their studies
with Lactobacillus GG, Lactobacillus acidophilus and Bifidobacterium bifidus, Larkin et al. [28]
suggested that β-glucuronidase activity might be more important than β-glucosidase
activity for isoflavone bioavailability.
Here, 42 bacterial strains (twenty-seven Lactobacillus, eight Streptococcus and seven
Enterococcus) were tested for their β-glucosidase activity under optimal growth conditions
(Figures 1 and 2). Regarding Lactobacillus strains (Figure 1), L. plantarum 128/2 showed
the highest levels of β-glucosidase activity (No. 18 = 43 ± 15 mU mL−1), followed by
L. plantarum LPC 01 nic 100 (No. 21 = 41.0 ± 0.3 mU mL−1) and L. plantarum MCMB 8826
(No. 19 = 28 ± 10 mU mL−1). The level of β-glucosidase activity shown by L. plantarum
128/2 and L. plantarum LPC 01 nic 100 was significantly (p < 0.05) higher, compared to all
the other strains (Figure 1).
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zymatic transformation of phenolic compounds [33]. Importantly, the adaptative behavior
of L. plantarum under phenolics-induced stress modulates several traits beneficial for its
gastrointe tinal survival [33]. These results emph size the import nce of species and strain
selection prior to the use of bacterial strains for the bioactivation of isoflavones.
In light of these results, L. plantarum 128/2 was selected for the study of the optimiza-
tion of the bioactivation of genistin and daidzin present in soymilk (commercial soymilk
No. 1) to their corresponding aglycone forms (genistein and daizein).
3.2. Bioactivation of Isoflavones in Soymilk
As described above, five commercial soy-based products (three milks, two yoghurts),
as well as the homemade soymilk, were analyzed regarding their content of isoflavones.
Commercial soymilk No. 1 clearly showed the highest content of isoflavone glycosides
(Figure 3). On the other hand, the homemade soymilk showed the highest content of
isoflavo e aglycones. In any eve t, th content f isoflavone (both glycosides and agly-
cones) varied considerably among the studied food products (Figure 3), possibly due to
differences in the content of isoflavones initially present in the raw material (soybeans) as
well as the specific industrial process conditions used to manufacture these food products
(milks and yoghurts). The five commercial soy-based products had a much higher content
of isoflavone glycosides (genistin and daidzin) than of isoflavone aglycones (genistein and
daidzein), suggesting their inadequacy for easy adsorption. By contrast, the homemade
soy milk had a much higher content of isoflavone aglycones than of isoflavone glycosides
(Figure 3). The total amount of isoflavones in soymilk products has been reported to vary
Processes 2021, 9, 963 8 of 13
considerably among the different commercial products and even among different lots of
the same product [34]. In their study on the quantification of isoflavones in soymilk and
tofu, Prabhakaran et al. [35] observed higher concentrations of isoflavones in soy foods
containing higher levels of protein content, compared to those with lower protein content.
Total isoflavone content has been reported to vary by up to five-fold among different com-
mercial soymilks, with whole soybean milks having significantly higher isoflavone levels
than those made from soy protein isolates (63.6 ± 21.9 mg L−1 vs. 30.2 ± 5.8 mg L−1) [36].
Likewise, the ratio of genistein to daidzein was higher in isolated soy protein-based ver-
sus “whole bean” soymilks (2.72 ± 0.24 vs. 1.62 ± 0.47, respectively, p < 0.0001) [36].
In any event, many studies have reported considerable variations in the content of soybean
isoflavones according to the conditions under which they are grown [37] or stored [38],
the maturity of the soybean [39], the specific strain of soybean, the geographical locations
of harvest [37,40,41], etc., pointing out to the great difficulty of producing a whole bean
soymilk with consistent isoflavone levels [36].
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According to the obtained results, commercial soymilk No. 1 was selected for the
study of the capacity of L. plantarum 128/2 to bioactivate soy isoflavone glycosides (genistin,
daidzin) to their corresponding aglycone forms (genistein, daizein). Although there is
controversy on this matter and contradictory findings [3,14,42–45], isoflavone aglycones
appear to be absorbed faster than isoflavone glycosides, and, in consequence, th aim of this
work was to optimize the bioactivation of isoflavones i soymilk using lactic acid bacteria.
In particular, as described above, for the optimization of this isoflavone bioactivation
process with L. plantarum 128/2, two temperatures (25 ◦C vs. 37 ◦C), two inoculum sizes
(2% vs. 10%) and two process times (24 h vs. 48 h) were compared.
Figure 4 shows the effect of temperature (25 ◦C vs. 37 ◦C) on the bioactivation of the
is flavone glycosides prese in commercial soymilk No. 1, thanks to the β-glucosidase
activity of L. plantarum 128/2, at an inoculum size of 2% and a process time of 24 h.
The bioactivation process (conversion of genistin and daidzin to genistein and daidzein)
was highly effective (though not complete) at both temperatures (Figure 4). At all times,
the content of genistin was higher compared to daidzin. Concerning aglycones, values of
genistein and daidzein contents were rather similar. In any case, the bioactivation was
somewhat more efficient at 37 ◦C vs. 25 ◦C. Actually, the point at which the lines showing
the decrease of glycoside contents intersect with the lines representing the increasing values
of aglycone contents (i.e., the equilibrium point) occurred at an earlier time at 37 ◦C vs.
25 ◦C. Nonetheless, the difference between both temperatures in terms of bioactivation
efficiency was rather small, which suggests the possibility of opting for 25 ◦C, in order to
save energy and money. In any case, a complete conversion of is flavone glycosides to
isoflavone aglycones was achieved neither at 37 ◦C nor at 25 ◦C.
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Nonetheless, the bioactivation of isoflavone glycosides to isoflavone aglycones was
incomplete under all the studied experimental conditions (Figures 4 and 5). For that reason,
it was decided to increase process time from 24 h to 48 h (Figure 6), using a temperature of
25 ◦C and an inoculum dose of 2%. At this longer process time, the bioactivation of the
is flavones (bioconversion of glycosides to aglycones) was complete. In any case, even un-
der hese more optimal conditions, glycosid s represented almost 100% of isoflavones,
while aglycones represented at most 65% of isoflavones (even when glycosides were
completely bioconverted). This is probably due to the production of other compounds
(e.g., malonylglucosides, acetylglucosides) [22].
Many Lactobacillus strains have previously been tested for their capacity to transform
isoflavone glycosides to aglycones in soymilk under different process conditions. For in-
stance, Hati et al. [46] fermented soymilk with six Lactobacillus strains (L. rhamnosus C6
and C2, L. rhamnosus NCDC19 and NCDC24, L. casei NCDC17 and NCDC297) at 37 ◦C
for 12 h. The highest β-glucosidase activity and isoflavone bioconversion was achieved
with L. rhamnosus C6 [46]. In a similar study to ours [21], one hundred and three strains of
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lactic acid bacteria were assayed for β-glucosidase activity, finding out that L. plantarum
DPPMA24W and DPPMASL33, L. fermentum DPPMA114, and L. rhamnosus DPPMAAZ1
had the highest activity values. These three strains were selected as mixed starter to fer-
ment soymilk made with organically farmed soybeans, and, after 96 h of fermentation,
the soymilk contained 57.0 µM daidzein, 140.3 µM genistein, 20.4 µM glycitein, and 37.3 µM
equol. Similarly, five Lactobacillus strains (L. acidophilus B4496, L. bulgaricus CFR2028, L. casei
B1922, L. plantarum B4495, L. fermentum B4655) were used for fermented soymilk isoflavone
bioactivation at 37 ◦C for 24 h and 48 h, in combination with the yeast Saccharomyces
boulardii, achieving very effective rates of bioactivation [47]. The novelty of such work was
that, since lactic acid bacteria often present poor survival in, for instance, yoghurt (due
to low pH and low acid tolerance), yeast can utilize the organic acids produced during
fermentation thereby increasing the pH of the environment and, hence, the viability of
the Lactobacillus strains. In another study [48], soymilk was fermented with Streptococcus
infantarius 12 and/or Weissella sp. 4 for 12 h at 37 ◦C, observing that the sharp increase in
β-glucosidase activity corresponded with a rapid decrease in isoflavone glycosides and
an increase in the aglycone forms. Marazza et al. [49] observed a high hydrolysis degree
of soymilk isoflavone glycosides (81.2%), with Bifidobacterium longum CRL849, after 24 h
at 37 ◦C. In the same way, five strains of bifidobacteria were screened for β-glucosidase
activity: Bifidobacterium animalis, B. longum-a, and B. pseudolongum caused hydrolysis of
isoflavone malonyl-, acetyl- and β-glycosides to form aglycones, and the transformed
daidzein to equol in soymilk [49].
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to isoflavone aglycones after 48 h.
Finally, several treatments have been studied in an attempt to optimize the bioactiva-
tion of soy isoflavones. For instance, Ewe et al. [50] evaluated the effects of ultrasounds on
Lactobacillus fermentum BT8633 growth and isoflavone bioconversion activity in soymilk,
finding out that the growth of ultrasonicated cells increased by 3.2–9.1%, compared to the
control. This increased growth was associated with enhanced intracellular and extracellu-
lar (8.4–17.0% and 16.7–49.2%, respectively) β-glucosidase activity, leading to increased
bioconversion of isoflavones glycosides to aglycones, possibly due to the reversible perme-
abilized membrane of ultrasonicated cells that facilitated the transport of molecules across
the membrane.
Then, it was concluded that L. plantarum 128/2, thanks to its great capacity to produce
β-glucosidase activity, was able to completely bioactivate soymilk isoflavones under the
following process conditions: 25 ◦C te perature, 2% inoculum dose, and 48 h process time.
These process conditions could most likely still be improved (e.g., by testing a process
time between 24 h and 48 h, an inoculum dose between 2% and 10%, etc.). In this study,
L. plantarum 128/2 has shown its great potential for th bi activation of isoflavones in
s ymilk, in order to improve its nutritional value.
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4. Conclusions
The 42 bacterial strains studied here showed varying levels of β-glucosidase activ-
ity, capable of driving the bioactivation of isoflavone glycosides to their corresponding
isoflavone aglycones. In any case, Lactobacillus plantarum 128/2 has shown its remarkable
capacity to produce β-glucosidase and, then, to stimulate the abovementioned bioacti-
vation of isoflavones in soymilk. Actually, L. plantarum 128/2, was able to completely
bioactivate soymilk isoflavones under the following process conditions: 25 ◦C temperature,
2% inoculum dose, and 48 h process time. These results confirm the suitability of lactic
acid bacteria for the bioactivation of isoflavones present in soymilk.
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